Sarah Bos

140 APPENDICES List of publications 1. Bos S , Grobbee DE, Boer JM, Verschuren WM, Beulens JW. Alchol consumption and risk of cardiovascular disease among hypertensive women. Eur J Cardiovasc Prev Rehabil. 2010 Feb;17(1):119-26. 2. Amraoui F, Bos S , Vogt L, van den Born BJ. Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study. BMC Nefrology. 2012 July 30;13:71. 3. Bos S , Nap R.R.H., Wouters R.S.M.E., van der Kleij F.G.H. Hypocitraturia: a common but not well-known cause of nephrolithiasis. Neth J of Med. 2014 Dec, vol. 72, no 10 4. Bos S , PotzeW, Siddiqui MS, Boyett SL, Adelmeijer J, Daita K, Lisman T, Sanyal AJ. Changes of in vitro potency of anticoagulant drugs are similar between patients with cirrhosis due to alcohol or non-alcoholic fatty liver disease. Thromb Res. 2017 Feb; 150:41-43 5. Bos S , Bernal W, Porte R, Lisman T. Hemostatic complications in hepatobiliary surgery. Semin Thromb Hemost. 2017 Oct;43(7):732-741 6. van Miert JHA, Bos S , Veeger NJGM, Meijer K. Clinical usefulness of the SAMe-TT2R2 score: A systematic review and simulation meta-analysis. PLoS One. 2018 Mar 13;13(3):e0194208 7. Lisman T, Bos S , Intagliata NM. Mechanisms of enhanced thrombin-generating capacity in patients with cirrhosis. J Thromb and Haemost 2018 Jun;16(6):1128-1131 8. Lisman T, Kleiss S, Patel VC, Fisher C, Adelmeijer J, Bos S , Singanayagam A, Stoy SH, Shawcross DL, Bernal W. In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis. Liver International 2018 9. Burlage LC, Bos S , Adelmeijer J, Sakai T, Porte RJ, Lisman T. Plasma from Patients undergoing Liver Transplantation is Resistant to Anticoagulant Activity of Soluble Thrombomodulin (ART-123). Liver Transpl. 2018 Aug 1 10. von Meijenfeldt FA, Burlage LC, Bos S , Adelmeijer J, Porte RJ, Lisman T. Elevated plasma levels of cell-free DNA during orthotopic liver transplantation are associated with activation of coagulation. Liver Transplantation 2018 Aug 31. 11. Bos S , van den Boom B, Kamphuisen PW, Adelmeijer J, Blokzijl H, Schreuder T, Lisman T. Haemostatic Profiles are Similar across All Aetiologies of Cirrhosis. Thromb Haemost. 2019 Feb;119(2):246-253. 12. Bos S , van den Boom B, Ow TW, Prachalias A, Adelmeijer J, Phoolchund A, Dunsire F, Milan Z, Roest M, Heaton N, Bernal W, Lisman T. Efficacy of pro- and anticoagulant strategies in plasma of patients undergoing hepatobiliary surgery. J Thromb Haemost. 2020 Nov;18(11):2840-2851. 13. Bos S , Schreuder T, Blokzijl H, Adelmeijer J, Lisman T, Kamphuisen PW. Anticoagulant activity of edoxaban in patients with cirrhosis. Blood. 2020 Sep 24;136(13):1561-1564.